
Antibiotic therapy for infective endocarditis: POET II trial backs shorter, tailored treatment
For decades, patients with infective endocarditis — a life-threatening infection of the heart’s inner lining and valves — have received lengthy courses of intravenous antibiotics, typically lasting four to six weeks. Now, new


